Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

End-of-phase II meeting for NRP-290

Oct. 18, 2006

Delay to gaboxadol NDA filing

Oct. 18, 2006

Wyeth presents the neuroprotective effects of novel Src kinase inhibitor in stroke

Oct. 17, 2006

Aricept approved for severe Alzheimer's disease

Oct. 17, 2006

Abbott and Icagen present a potent and selective Nav1.8 blocker with analgesic efficacy

Oct. 17, 2006

SCH-697466: a novel gamma-secretase inhibitor profiled at the SfN meeting

Oct. 17, 2006

AMG-517, a novel TRPV1 antagonist, from Amgen

Oct. 17, 2006

New agents for depression, psychosis, sleep disorders, etc., patented

Oct. 17, 2006

EKR Therapeutics acquires North American rights for Gelclair

Oct. 17, 2006

Hsp90 inhibition activates Fas apoptotic pathway in cultured motor neurons

Oct. 17, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026